BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33647953)

  • 1. The Role of Surgery in IDH-Wild-Type Lower-Grade Gliomas: Threshold at a High Extent of Resection Should be Pursued.
    Wang P; Luo C; Hong PJ; Rui WT; Wu S
    Neurosurgery; 2021 May; 88(6):1136-1144. PubMed ID: 33647953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.
    Patel T; Bander ED; Venn RA; Powell T; Cederquist GY; Schaefer PM; Puchi LA; Akhmerov A; Ogilvie S; Reiner AS; Moussazadeh N; Tabar V
    Neurosurgery; 2018 Jun; 82(6):808-814. PubMed ID: 28945860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
    Sanai N; Polley MY; Berger MS
    J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.
    Scherer M; Ahmeti H; Roder C; Gessler F; Jungk C; Pala A; Mayer B; Senft C; Tatagiba M; Synowitz M; Wirtz CR; Unterberg AW; Coburger J
    Neurosurgery; 2020 Jan; 86(1):E64-E74. PubMed ID: 31574147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.
    Motomura K; Chalise L; Ohka F; Aoki K; Tanahashi K; Hirano M; Nishikawa T; Yamaguchi J; Shimizu H; Wakabayashi T; Saito R
    J Neurooncol; 2021 Jun; 153(2):361-372. PubMed ID: 34009509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.
    Eseonu CI; Eguia F; ReFaey K; Garcia O; Rodriguez FJ; Chaichana K; Quinones-Hinojosa A
    J Neurooncol; 2017 Aug; 134(1):65-74. PubMed ID: 28527004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
    J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.
    Tom MC; Varra V; Leyrer CM; Park DY; Chao ST; Yu JS; Suh JH; Reddy CA; Balagamwala EH; Broughman JR; Kotagal KA; Vogelbaum MA; Barnett GH; Ahluwalia MS; Peereboom DM; Prayson RA; Stevens GHJ; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1099-1105. PubMed ID: 31022510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas.
    Rossi M; Gay L; Ambrogi F; Conti Nibali M; Sciortino T; Puglisi G; Leonetti A; Mocellini C; Caroli M; Cordera S; Simonelli M; Pessina F; Navarria P; Pace A; Soffietti R; Rudà R; Riva M; Bello L
    Neuro Oncol; 2021 May; 23(5):812-826. PubMed ID: 33049063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
    J Neurosurg; 2019 Feb; 132(2):518-529. PubMed ID: 30717057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
    Kavouridis VK; Boaro A; Dorr J; Cho EY; Iorgulescu JB; Reardon DA; Arnaout O; Smith TR
    J Neurosurg; 2019 Oct; 133(5):1291-1301. PubMed ID: 31653812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
    Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ
    Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations.
    Izquierdo C; Barritault M; Poncet D; Cartalat S; Joubert B; Bruna J; Jouanneau E; Guyotat J; Vasiljevic A; Fenouil T; Berthezène Y; Honnorat J; Meyronet D; Ducray F
    Neurosurgery; 2019 Sep; 85(3):E448-E456. PubMed ID: 30407589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.